2 Treatment groups Experimental Treatment Active Control Participants will receive 2.4 mg cagrilintide and 2.4 mg semaglutide subcutaneously once-weekly (dose escalation period of 16 weeks) for up to 84 weeks
Shekunova EV, Kashkin VA, Muzhikyan Acapital AC, Makarova MN, Balabanyan VY, Makarov VG (2020) Therapeutic efficacy of arginine-rich exenatide on diabetic neuropathy in rats
This expanding science reinforces that GLP-1 medications arent just a fad they may be a foundational shift in treating chronic metabolic conditions
Pot weight (including pot soil) for each treatment was calculated by weighing of completely dry soil and amount of water required for attaining respective field capacity
The term covers a wide range of business models, from single-vial research vendors to large-scale pharmaceutical CDMOs
You may be wondering: Is Ozempic the same as Wegovy